Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Follicular 2Lymphoma 2Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 16Vincristine 12Doxorubicin 11Radiotherapy 10Etoposide 9Prednisone 8Peripheral Blood Stem Cell Transplantation 8VAP-cyclo protocol 6Filgrastim 6Rituximab 5Mitoxantrone 5Melphalan 5Cytarabine 5Carmustine 4Bleomycin 4Prednisolone 3Methylprednisolone 3Methotrexate 3Idarubicin 3liposomal amphotericin B 2aldesleukin 2Therapeutics 2Psychiatric Rehabilitation 2Levofloxacin 2Leucovorin 2Interferon-alpha 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Epoetin Alfa 2Early Intervention, Educational 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma, Large-Cell, Immunoblastic × epratuzumab × Clear all
NCT00003337 2021-08-16

Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma

Gilead Sciences

Phase 3 Unknown
100 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡